Cargando…
Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505540/ https://www.ncbi.nlm.nih.gov/pubmed/36964916 http://dx.doi.org/10.1210/clinem/dgad171 |
| _version_ | 1785106932283998208 |
|---|---|
| author | van Velsen, Evert F S Verburg, Frederik A |
| author_facet | van Velsen, Evert F S Verburg, Frederik A |
| author_sort | van Velsen, Evert F S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10505540 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105055402023-09-19 Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat van Velsen, Evert F S Verburg, Frederik A J Clin Endocrinol Metab Commentary Oxford University Press 2023-03-25 /pmc/articles/PMC10505540/ /pubmed/36964916 http://dx.doi.org/10.1210/clinem/dgad171 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Commentary van Velsen, Evert F S Verburg, Frederik A Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat |
| title | Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat |
| title_full | Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat |
| title_fullStr | Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat |
| title_full_unstemmed | Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat |
| title_short | Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat |
| title_sort | adjuvant radioiodine for intermediate-risk papillary thyroid cancer—to treat or not to treat |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505540/ https://www.ncbi.nlm.nih.gov/pubmed/36964916 http://dx.doi.org/10.1210/clinem/dgad171 |
| work_keys_str_mv | AT vanvelsenevertfs adjuvantradioiodineforintermediateriskpapillarythyroidcancertotreatornottotreat AT verburgfrederika adjuvantradioiodineforintermediateriskpapillarythyroidcancertotreatornottotreat |